These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Indications of anticoagulant and fibrinolytic drugs in the prevention and therapy of thromboembolic diseases]. Verstraete M. Clin Ter; 1975 Jun 15; 73(5):403-22. PubMed ID: 1139864 [No Abstract] [Full Text] [Related]
3. [Thrombolytic therapy]. Schimpf K. Dtsch Med Wochenschr; 1969 Oct 31; 94(44):2292-4. PubMed ID: 5350098 [No Abstract] [Full Text] [Related]
4. [Fibrinolytics. 46]. Wagler M. Pharm Prax; 1970 Oct 31; 6():141-2. PubMed ID: 4195438 [No Abstract] [Full Text] [Related]
5. [Thrombolytic agents and substances with "minor fibrinolytic" effect]. Verstraete M, Amery A. Rev Atheroscler (Paris); 1968 Oct 31; 10(2):21-7. PubMed ID: 5759946 [No Abstract] [Full Text] [Related]
9. [Current data on diagnosis and treatment of thromboembolic states]. Zosin P, Roth L. Med Interna (Bucur); 1972 Aug 31; 24(8):947-58. PubMed ID: 5080893 [No Abstract] [Full Text] [Related]
16. Guidelines for the use of thrombolytic therapy. Haemostasis and Thrombosis Task Force of the British Committee for Standards in Haematology. Ludlam CA, Bennett B, Fox KA, Lowe GD, Reid AW. Blood Coagul Fibrinolysis; 1995 May 31; 6(3):273-85. PubMed ID: 7654941 [No Abstract] [Full Text] [Related]